Lamisil Solo (Terbinafine)

Terbinafine belongs to the allylamine class of antifungals. It inhibits the fungal enzyme squalene epoxidase, disrupting the synthesis of ergosterol, a vital component of fungal cell membranes. This leads to toxic accumulation of squalene and loss of membrane integrity, ultimately killing the fungus.

The specific dosing regimen for Lamisil Solo is determined by the prescribing healthcare professional. Typically, a thin layer is applied once daily to the clean, dry skin of the affected area for a period that may range from one to four weeks, depending on the infection type and severity.

Safety data for topical terbinafine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider.

To request Lamisil Solo, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Lamisil Solo (terbinafine) is an allylamine, which works by inhibiting squalene epoxidase, whereas azole antifungals block lanosterol 14‑α‑demethylase. Terbinafine often requires a shorter treatment duration for dermatophyte infections and has a different side‑effect profile, making it a useful alternative when azoles are ineffective or not tolerated.

Store Lamisil Solo at room temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain stability and potency.

Apply a thin layer of the cream or gel to the clean, dry skin of the affected area once daily, as directed by a healthcare professional. Gently rub it in until fully absorbed, and wash hands after application to avoid accidental contact with eyes or mucous membranes.

Although rare, serious adverse reactions can include severe allergic responses such as angioedema or anaphylaxis, extensive contact dermatitis, and, in exceptional cases, systemic toxicity like hepatotoxicity. Patients should discontinue use and seek immediate medical attention if they experience swelling, difficulty breathing, or signs of liver dysfunction.

Individuals with a known hypersensitivity to terbinafine, other allylamine antifungals, or any component of the formulation should avoid using Lamisil Solo. It is also contraindicated on broken, inflamed, or mucosal skin, and should be used with caution in patients with pre‑existing liver disease.